Thus, we investigated the functional relationship of FOXD2‐AS1, miR‐206, and MAP3K1, and hypothesized that FOXD2‐AS1 can regulate HCC progression by modulating miR‐206 and MAP3K1 expression. This evidence concerns the gene MAP3K1 and hepatocellular carcinoma.